Fundraising Fox

Trailhead Biosystems

Beachwood, US · Delaware corporation · 1 known investors

trailbio.com ↗

Trailhead Biosystems develops HD-DoE (High-Dimensional Design-of-Experiments), a platform that uses computational models and control systems to differentiate human induced pluripotent stem cells (iPSCs) into specific cell types for regenerative medicine and stem cell research. The company serves stem cell researchers and cell-therapy developers with iPSC research products and differentiation technologies.

AI & Machine LearningBiotechDeep TechMedical Devicesin /trailhead-biosystems-inc-

Founders & leadership

JJ
Jan JensenFounder
JS
Joshua SnowChief Commercial Officer
DT
Divya TrivediChief Operating Officer and Secretary
DL
David LlewellynPresident & CEO
MP
Magnus PerssonChairman
JS
Josh SnowChief Commercial Officer
JA
Jennifer AntonchukVice President of Research and Development
MK
Michael KaufmanDirector
CN
Craig NemiroffDirector
WH
Wolfgang HofmannDirector
HH
Houman HemmatiDirector

Investors · 1

CWRU Technology VenturesCleveland · $50K – $250K

Reported raises · per SEC filings

Form D private placements
▶$40.6MraisedJul 2026 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David LlewellynExecutive Officer, Director
  • Craig NemiroffDirector
  • Joshua SnowExecutive Officer
  • Wolfgang HofmannDirector
  • Houman HemmatiDirector
  • Divya TrivediExecutive Officer
  • Michael KaufmanExecutive Officer, Director
  • Jan JensenDirector
Offering amount
$40.6M
Amount sold
$40.6M
Minimum investment
$50K
First sale
Jun 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedNov 2023 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Divya TrivediExecutive Officer
  • Magnus PerssonDirector
  • Michael KaufmanDirector
  • Houman HemmatiDirector
  • Jan JensenExecutive Officer, Director
Offering amount
$3M
Amount sold
$3M
Minimum investment
$25K
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$10MraisedSep 2022 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Divya TrivediExecutive Officer
  • Magnus PerssonDirector
  • Houman HemmatiDirector
  • Jan JensenExecutive Officer, Director
  • Michael KaufmanDirector
Offering amount
$10.1M
Amount sold
$10M
Minimum investment
$25K
First sale
Sep 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.6MraisedOct 2021 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael A. KaufmanDirector
  • Jan JensenExecutive Officer, Director
  • Div TrivediExecutive Officer
  • Magnus PerssonDirector
  • Houman HemmatiDirector
Offering amount
$8.6M
Amount sold
$8.6M
Minimum investment
$25K
First sale
Oct 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$100KraisedJun 2020 · 3 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Div TrivediExecutive Officer
  • Magnus PerssonDirector
  • Jan JensenExecutive Officer, Director
Offering amount
$2M
Amount sold
$100K
Minimum investment
$25K
Proceeds to insiders
$100K
First sale
Jun 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.